Neuberger Berman Group’s Cytosorbents Corp CTSO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.03M | Sell |
1,591,689
-87,939
| -5% | -$112K | ﹤0.01% | 1157 |
|
|
2025
Q1 | $1.7M | Sell |
1,679,628
-2,255
| -0.1% | -$2.28K | ﹤0.01% | 1174 |
|
|
2024
Q4 | $1.53M | Sell |
1,681,883
-99,477
| -6% | -$90.4K | ﹤0.01% | 1206 |
|
|
2024
Q3 | $2.67M | Buy |
1,781,360
+244,846
| +16% | +$367K | ﹤0.01% | 1065 |
|
|
2024
Q2 | $1.08M | Sell |
1,536,514
-376,052
| -20% | -$264K | ﹤0.01% | 1253 |
|
|
2024
Q1 | $1.81M | Buy |
1,912,566
+110,767
| +6% | +$105K | ﹤0.01% | 1139 |
|
|
2023
Q4 | $2M | Buy |
1,801,799
+299,103
| +20% | +$331K | ﹤0.01% | 1107 |
|
|
2023
Q3 | $2.82M | Buy |
1,502,696
+14,051
| +0.9% | +$26.4K | ﹤0.01% | 1010 |
|
|
2023
Q2 | $5.34M | Sell |
1,488,645
-59,278
| -4% | -$213K | ﹤0.01% | 877 |
|
|
2023
Q1 | $5.23M | Buy |
1,547,923
+18,828
| +1% | +$63.6K | ﹤0.01% | 868 |
|
|
2022
Q4 | $2.33M | Buy |
1,529,095
+49,525
| +3% | +$75.4K | ﹤0.01% | 1039 |
|
|
2022
Q3 | $2M | Buy |
1,479,570
+151,300
| +11% | +$205K | ﹤0.01% | 1080 |
|
|
2022
Q2 | $2.92M | Buy |
1,328,270
+76,458
| +6% | +$168K | ﹤0.01% | 1030 |
|
|
2022
Q1 | $3.98M | Sell |
1,251,812
-4,256
| -0.3% | -$13.5K | ﹤0.01% | 1024 |
|
|
2021
Q4 | $5.26M | Sell |
1,256,068
-4,506
| -0.4% | -$18.9K | ﹤0.01% | 964 |
|
|
2021
Q3 | $10.2M | Buy |
1,260,574
+413,485
| +49% | +$3.35M | 0.01% | 803 |
|
|
2021
Q2 | $6.39M | Sell |
847,089
-16,725
| -2% | -$126K | 0.01% | 902 |
|
|
2021
Q1 | $7.47M | Sell |
863,814
-49,335
| -5% | -$427K | 0.01% | 872 |
|
|
2020
Q4 | $7.27M | Buy |
913,149
+330,555
| +57% | +$2.63M | 0.01% | 842 |
|
|
2020
Q3 | $4.65M | Buy |
+582,594
| New | +$4.65M | 0.01% | 873 |
|